期刊文献+

人类白细胞抗原G基因5’上游调控区多态性与慢性丙型病毒性肝炎病毒载量的关系

下载PDF
导出
摘要 目的探讨人类白细胞抗原G(HLA-G)基因5’上游调控区(URR)多态性与慢性丙型病毒性肝炎(简称丙型肝炎)病毒(HCV)载量的相关性。方法回顾性分析2015年4—12月在大连市公共卫生临床中心(原大连市第六人民医院)住院并确诊为慢性丙型肝炎的195例患者的临床资料。收集患者血样并提取基因组DNA和病毒核酸,采用聚合酶链式反应扩增HLA-G 5’-URR,然后使用基因测序技术检测患者HLA-G 5’-URR的16个多态性位点,采用定量PCR方法测定患者血清HCV病毒载量,分析HLA-G基因5’-URR基因多态性与HCV病毒载量的关系。结果195例慢性HCV感染者HLA-G基因5’-URR的16个多态性位点中,-762C>T、-725C>G>T、-716T>G、-689A>G、-666G>T、-633G>A、insG540、-509C>G、-486A>C、-443G>A、-400G>A、-398A>G、-201G>A和-56C>T 14个位点不同基因型患者的HCV病毒载量差异无统计学意义(P>0.05),而-477C>G、-369C>A 2个位点不同基因型患者的HCV病毒载量差异有统计学意义(P<0.05)。两两比较结果显示,-477C>G位点CG基因型的HCV病毒载量高于GG基因型(P<0.05),-369C>A位点AC基因型的病毒载量高于AA基因型(P<0.05)。结论HLA-G基因5’-URR-477C>G位点CG基因型的HCV病毒载量高于GG基因型,-369C>A位点AC基因型的HCV病毒载量高于AA基因型,可能与HLA-G的表达水平改变有关。
机构地区 大连市血液中心
出处 《中国医刊》 CAS 2024年第7期805-808,共4页 Chinese Journal of Medicine
  • 相关文献

参考文献4

二级参考文献90

  • 1Michael.达人巴黎行[J].网球大师,2013,0(6):100-102. 被引量:10
  • 2Wei Hua YAN,Ai Fen LIN,Chien Chung CHANG,Soldano FERRONE.Induction of HLA-G expression in a melanoma cell line OCM-1A following the treatment with 5-aza-2'-deoxycytidine[J].Cell Research,2005,15(7):523-531. 被引量:5
  • 3H Le Guillou-Guillemette,S Vallet,C Gaudy-Graffin,C Payan,A Pivert,A Goudeau,F Lunel-Fabiani.Genetic diversity of the hepatitis C virus: Impact and issues inthe antiviral therapy[J].World Journal of Gastroenterology,2007,13(17):2416-2426. 被引量:6
  • 4Argentini, Claudio,Genovese, Domenico,Dettori, Stefano,Rapicetta, Maria.HCV genetic variability: from quasispecies evolution to genotype classification[J]. Future Microbiology . 2009 (3)
  • 5Ralf Bartenschlager,Francois Penin,Volker Lohmann,Patrice André.Assembly of infectious hepatitis C virus particles[J].Trends in Microbiology.2010(2)
  • 6Kris V. Kowdley,Stuart C. Gordon,K. Rajender Reddy,Lorenzo Rossaro,David E. Bernstein,Eric Lawitz,Mitchell L. Shiffman,Eugene Schiff,Reem Ghalib,Michael Ryan,Vinod Rustgi,Mario Chojkier,Robert Herring,Adrian M. Di Bisceglie,Paul J. Pockros,G. Mani Subramanian,Di An,Evguenia Svarovskaia,Robert H. Hyland,Phillip S. Pang,William T. Symonds,John G. McHutchison,Andrew J. Muir,David Pound,Michael W. Fried.??Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis(J)The New England Journal of Medicine . 2014 (20)
  • 7Eric Lawitz,Mark S Sulkowski,Reem Ghalib,Maribel Rodriguez-Torres,Zobair M Younossi,Ana Corregidor,Edwin DeJesus,Brian Pearlman,Mordechai Rabinovitz,Norman Gitlin,Joseph K Lim,Paul J Pockros,John D Scott,Bart Fevery,Tom Lambrecht,Sivi Ouwerkerk-Mahadevan,Katleen Callewaert,William T Symonds,Gaston Picchio,Karen L Lindsay,Maria Beumont,Ira M Jacobson.??SJES14121200025593(J)The Lancet . 2014 (9956)
  • 8Sulkowski MS,Gardiner DF,Rodriguez-Torres M,et al.Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection. The New England Journal of Medicine . 2014
  • 9Simmonds P,Bukh J,Combet C,et al.Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology . 2005
  • 10Zeuzem S,Jacobson I M,Baykal T,et al.Retreatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin. New England Journal of Homeopathy . 2014

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部